论文信息 - A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC). - 字舞流文

A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC).

W. Pao | D. Carbone | A. Hutchison | N. Venepalli | D. Johnson | L. Horn | V. Keedy | A. Sandler